skip to main content

C. difficile — SCE Infectious Diseases MCQ

Instant feedback + full explanation. One question, done properly.

ModerateHealthcare-Associated InfectionsC. difficileSCE Infectious Diseases

A 45-year-old woman with recurrent C. difficile infection (3rd episode within 6 months) has failed both oral Vancomycin taper and Fidaxomicin extended-pulse regimen. What is the most appropriate next-line intervention?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: CFaecal microbiota transplantation (FMT)

FMT is recommended for recurrent CDI (≥2 recurrences) that has failed standard antibiotic therapy. Multiple RCTs demonstrate FMT superiority over repeated antibiotics with cure rates of 80–90% for recurrent CDI. In the UK, FMT is available through regulated stool banks. Bezlotoxumab (anti-toxin B monoclonal antibody) is an adjunct to antibiotics to prevent recurrence but is not a standalone treatment. Metronidazole is no longer appropriate.

Reference: NICE NG199 2021 – C. difficile infection; BSG 2018 – FMT guidelines